AESKU is engaged in the development of in-vitro diagnostic products for the treatment of autoimmune diseases... Read more
AESKU is engaged in the development of in-vitro diagnostic products for the treatment of autoimmune diseases... Read more
Founder & CEO
Torsten Matthias
News
Aug 01, 2019
BioPortfolio
AESKU.Diagnostics: AESKU.GROUP Completes Acquisition of IFA Specialist MBL Bion
Mar 07, 2019
BioPortfolio
AESKU.Diagnostics: AESQC.com Web Portal a Quality Control Resource Now Available from AESKU
Mar 06, 2019
BioPortfolio
AESKU.Diagnostics: AESQC IFA Products Receive CE Marking FDA Registration
Jul 25, 2018
BioPortfolio
AESKU.Diagnostics: ICAP Compatible IFA Quality Controls Now Available from AESKU
Apr 04, 2018
PRWeb
Press Release: AESKU.Diagnostics : FDA Clears Automated Vasculitis Test from AESKU
Mar 15, 2018
360DX
AESKU.Diagnostics: FDA Clears Lupus Assay From AESKU
Jun 22, 2017
PRWeb
Press Release: AESKU.Diagnostics : AESKU.GROUP Acquires DST Diagnostische Systeme & Technologien GmbH
Jul 16, 2015
NEWSWISE
Press Release: AESKU.Diagnostics : The Return of IFA
Jun 06, 2014
BIOSPACE
AESKU.DIAGNOSTICS: Eight Startups Set Up Shop In Buffalo, Will Create 204 New Jobs; Companies Include Lineagen Inc., And Sinapis Pharma